Abbott trial on preterm infant formula linked to NEC disease kicks off this week
![Abbott trial on preterm infant formula linked to NEC disease kicks off this week](https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/wp-cms-2/2024/07/p-2-91152192-abbott-infant-formula-trial.jpg)
Gill alleges in the lawsuit that her premature infant child developed necrotizing enterocolitis (NEC) as a result of being fed Abbott’s products for premature babies.
Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel disease, the second trial out of hundreds of similar lawsuits in the United States.